The Neuronal Ischemic Tolerance Is Conditioned by the Tp53 Arg72Pro Polymorphism.
Aged
Aged, 80 and over
Animals
Apoptosis
/ genetics
Arginine
/ genetics
Brain Ischemia
/ genetics
Caspase 3
/ metabolism
Cell Hypoxia
/ genetics
Cells, Cultured
Cerebral Cortex
/ cytology
Cohort Studies
Electron Transport Complex IV
/ metabolism
Embryo, Mammalian
Excitatory Amino Acid Agonists
/ pharmacology
Female
Glucose
/ deficiency
Humans
Ischemic Preconditioning
/ methods
Male
Membrane Potentials
/ genetics
Mice
Microtubule-Associated Proteins
/ metabolism
Middle Aged
N-Methylaspartate
/ pharmacology
Neurons
/ pathology
Polymorphism, Single Nucleotide
/ genetics
Proline
/ genetics
Subcellular Fractions
/ metabolism
Tumor Suppressor Protein p53
/ genetics
Ischemic tolerance
Neuroprotection
Preconditioning
Tp53 Arg72Pro polymorphism
Transient ischemic attack
Journal
Translational stroke research
ISSN: 1868-601X
Titre abrégé: Transl Stroke Res
Pays: United States
ID NLM: 101517297
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
06
02
2018
accepted:
06
04
2018
revised:
03
04
2018
pubmed:
25
4
2018
medline:
16
4
2019
entrez:
25
4
2018
Statut:
ppublish
Résumé
Cerebral preconditioning (PC) confers endogenous brain protection after stroke. Ischemic stroke patients with a prior transient ischemic attack (TIA) may potentially be in a preconditioned state. Although PC has been associated with the activation of pro-survival signals, the mechanism by which preconditioning confers neuroprotection is not yet fully clarified. Recently, we have described that PC-mediated neuroprotection against ischemic insult is promoted by p53 destabilization, which is mediated by its main regulator MDM2. Moreover, we have previously described that the human Tp53 Arg72Pro single nucleotide polymorphism (SNP) controls susceptibility to ischemia-induced neuronal apoptosis and governs the functional outcome of patients after stroke. Here, we studied the contribution of the human Tp53 Arg72Pro SNP on PC-induced neuroprotection after ischemia. Our results showed that cortical neurons expressing the Pro72-p53 variant exhibited higher PC-mediated neuroprotection as compared with Arg72-p53 neurons. PC prevented ischemia-induced nuclear and cytosolic p53 stabilization in Pro72-p53 neurons. However, PC failed to prevent mitochondrial p53 stabilization, which occurs in Arg72-p53 neurons after ischemia. Furthermore, PC promoted neuroprotection against ischemia by controlling the p53/active caspase-3 pathway in Pro72-p53, but not in Arg72-p53 neurons. Finally, we found that good prognosis associated to TIA within 1 month prior to ischemic stroke was restricted to patients harboring the Pro72 allele. Our findings demonstrate that the Tp53 Arg72Pro SNP controls PC-promoted neuroprotection against a subsequent ischemic insult by modulating mitochondrial p53 stabilization and then modulates TIA-induced ischemic tolerance.
Identifiants
pubmed: 29687302
doi: 10.1007/s12975-018-0631-1
pii: 10.1007/s12975-018-0631-1
pmc: PMC6421278
doi:
Substances chimiques
Excitatory Amino Acid Agonists
0
Microtubule-Associated Proteins
0
Mtap2 protein, mouse
0
Trp53 protein, mouse
0
Tumor Suppressor Protein p53
0
N-Methylaspartate
6384-92-5
Arginine
94ZLA3W45F
Proline
9DLQ4CIU6V
Electron Transport Complex IV
EC 1.9.3.1
Caspase 3
EC 3.4.22.-
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
204-215Références
Brain Res Mol Brain Res. 1999 Jul 5;70(2):304-13
pubmed: 10407180
Stroke. 1999 Sep;30(9):1851-4
pubmed: 10471435
J Biol Chem. 2000 May 26;275(21):16202-12
pubmed: 10821866
Neurology. 2000 Jun 13;54(11):2089-94
pubmed: 10851368
J Neurochem. 2000 Aug;75(2):812-8
pubmed: 10899959
Neurology. 2000 Dec 12;55(11):1649-55
pubmed: 11113218
FEBS Lett. 2001 Jan 19;488(3):110-5
pubmed: 11163756
J Neurosci. 2001 Sep 1;21(17):6608-16
pubmed: 11517250
Cancer Lett. 2001 Dec 10;174(1):1-15
pubmed: 11675147
Biochem Soc Trans. 2001 Nov;29(Pt 6):684-8
pubmed: 11709054
Stroke. 2002 Jun;33(6):1698-705
pubmed: 12053014
J Neurochem. 2002 Apr;81(2):207-17
pubmed: 12064468
J Neurol. 2002 Nov;249(11):1503-11
pubmed: 12420088
Trends Neurosci. 2003 May;26(5):248-54
pubmed: 12744841
J Clin Immunol. 2003 Sep;23(5):355-61
pubmed: 14601643
Stroke. 2004 Mar;35(3):616-21
pubmed: 14963288
Nat Cell Biol. 2004 May;6(5):443-50
pubmed: 15077116
J Neurosci Res. 2004 Oct 1;78(1):132-40
pubmed: 15372497
J Mol Neurosci. 2004;24(2):299-305
pubmed: 15456943
Cell Cycle. 2004 Dec;3(12):1492-5
pubmed: 15611631
Trends Genet. 2005 Mar;21(3):182-7
pubmed: 15734577
Biochem Biophys Res Commun. 2005 Jun 10;331(3):843-50
pubmed: 15865940
J Neurosci Res. 2005 Dec 1;82(5):665-73
pubmed: 16247804
J Neurosci. 2006 Apr 26;26(17):4509-18
pubmed: 16641230
J Neurosci Res. 2006 Jul;84(1):130-41
pubmed: 16688719
Stroke. 2007 Mar;38(3):1091-6
pubmed: 17272767
EMBO J. 2008 Oct 22;27(20):2736-45
pubmed: 18818692
J Cereb Blood Flow Metab. 2009 Feb;29(2):375-84
pubmed: 18957990
Neurobiol Dis. 2009 Mar;33(3):509-17
pubmed: 19166937
Stroke. 2009 Jun;40(6):2276-93
pubmed: 19423857
Transl Stroke Res. 2010 Jan 14;1(1):4-18
pubmed: 20563278
Cancer Res. 2010 Jul 15;70(14):5851-9
pubmed: 20587514
J Exp Med. 2011 Mar 14;208(3):429-37
pubmed: 21357744
J Neurol Neurosurg Psychiatry. 2011 Sep;82(9):993-1000
pubmed: 21357987
Neurologia. 2014 Mar;29(2):102-22
pubmed: 22152803
Cell Mol Life Sci. 2013 Jan;70(1):71-88
pubmed: 22695677
Genes Cancer. 2012 Mar;3(3-4):240-8
pubmed: 23150757
Curr Opin Neurol. 2013 Feb;26(1):1-7
pubmed: 23197083
Nat Commun. 2013;4:2879
pubmed: 24301314
Prog Neurobiol. 2014 Mar;114:58-83
pubmed: 24389580
Biochim Biophys Acta. 2014 Aug;1842(8):1186-97
pubmed: 24412988
Lancet. 2014 Nov 29;384(9958):1929-35
pubmed: 25106063
Aging Dis. 2014 Feb 12;5(6):430-41
pubmed: 25489494
Cell Death Differ. 2017 Jan;24(1):144-154
pubmed: 27768124
Arch Med Sci. 2017 Aug;13(5):1057-1061
pubmed: 28883846
Sci Rep. 2018 Jan 25;8(1):1610
pubmed: 29371613
Brain Pathol. 1995 Apr;5(2):135-44
pubmed: 7670654
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
Stroke. 1997 May;28(5):1073-80; discussion 1080-1
pubmed: 9158652
J Cereb Blood Flow Metab. 1998 Mar;18(3):238-47
pubmed: 9498840
Brain Res Brain Res Protoc. 1998 Mar;2(3):209-14
pubmed: 9507134
Stroke. 1998 Sep;29(9):1937-50; discussion 1950-1
pubmed: 9731622